Exact Mass: 505.0840984
Exact Mass Matches: 505.0840984
Found 28 metabolites which its exact mass value is equals to given mass value 505.0840984
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyanidin 3-O-(6'-malonyl-arabinoside)
Cyanidin 3-O-(6-malonyl-arabinoside) is a polyphenol compound found in foods of plant origin (PMID: 20428313)
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
C21H22F3NO8S (505.10181680000005)
Desmethyl dabrafenib
Cyanidin 3-O-(6-malonyl-arabinoside)
sodium 6-amino-4-hydroxy-5-[[2-(phenylsulphonyl)phenyl]azo]naphthalene-2-sulphonate
C22H16N3NaO6S2 (505.03781960000003)
azanium,sodium,2,4-dimethylbenzenesulfonic acid,formaldehyde,4-(4-oxidophenyl)sulfonylphenolate
acetonitrile,1,2,3,4,5-pentamethylcyclopenta-1,3-diene,ruthenium(1+),hexafluorophosphate
Omipalisib
C25H17F2N5O3S (505.1020116000001)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3]. Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3].
Amustaline Dihydrochloride
C22H27Cl4N3O2 (505.08572820000006)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
C21H22F3NO8S (505.10181680000005)
2,4-difluoro-N-[2-methoxy-4-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
C25H17F2N5O3S (505.1020116000001)
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide
C21H23N5O4S3 (505.09121180000005)
2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
2-[(4-chlorophenyl)sulfonylamino]-N-[2-(4-morpholinyl)-2-thiophen-2-ylethyl]benzamide
C23H24ClN3O4S2 (505.08966940000005)
(2r,3s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-3-methyl-2-(methylamino)pentanimidic acid
C20H33Br2N3O2 (505.09393580000005)
1-[(2r,3r,4s,5r)-5-({[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid
(2s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid
C20H33Br2N3O2 (505.09393580000005)
n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid
C20H33Br2N3O2 (505.09393580000005)